(Date:11/24/2009)...,, SANMATEO,Calif.,Nov.24/PRNewswire-FirstCal...alcompanyfocusedondevelopingandcommercializingnove...DiTonno,PresidentandChiefExecutiveOfficer,isschedu...onference,tobeheldDecember1-2,2009atTheNewYorkPala...enGhiglieri,ChiefFinancialOfficer,willbeavailablet...
(Date:11/24/2009)...,, ,Primaryefficacyendpointhasbeenmetforpatien... , QUEBECCITY,Nov.24/PRNewswire-FirstCall/-AE...ny"),aglobalbiopharmaceuticalcompanyfocusedonendoc...acydatafromaPhase2studywithitstargetedcytotoxicpep...ithadvancedorrecurrentendometrialcancer.Inapersona...
(Date:11/24/2009)...,, REDWOODCITY,Calif.,Nov.24/PRNewswire-First...ncedthatRandyScott,GenomicHealth,sExecutiveChairma...ConferenceinNewYorkCityonTuesday,December1,2009at1...chivedwebcastofthepresentation,visittheInvestorRel...estor.genomichealth.com .Pleaseconnecttothewebsite...
(Date:11/24/2009)...,, SEATTLE,Nov.24/PRNewswire-FirstCall/--Cell...twillpresentatthe21stAnnualPiperJaffrayHealthCareC...attheNewYorkPalaceHotel. ,, CTIwillpresentonTue...loor).AliveaudiowebcastofCTI,spresentationwillbeav...eavailableforreplayafterwards. , ,PiperJaffrayHea...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2... Award Recognizes Leadership in Technology and Inn...., March 4 Lockheed Martin (NYSE: LMT ) has bee... of the Year" by Frost and Sullivan, recognizing t...ve biometrics solutions for a wide range of custom...ous analysis of the worldwide biometrics marketpla...
... , COLLEGE PARK, Md. There,s no "silver bullet" f... and acquisition policies, but they do need reform...fessor Jacques Gansler, who testified today before...directed the Defense Department,s acquisition oper...rved as a consultant for the Pentagon in interveni...
... Research into RNA, a molecule found in every cel... in the treatment of diseases such as cancer and d...ce Foundation was told. , The conference, held th...yra", CSIC in Granada, Spain, on 23 February 2009,...nt strategy for RNA research in Europe in recognit...
Other Biology News:Lockheed Martin Named Biometrics 'Company of the Year' by Frost and Sullivan 2Reforming defense department acquisition policy: UM expert 2RNA research strategy for Europe takes shape 2...ists of universal lysis buffer, PCR mix, DNA polym...olume PCR reactions. This system can detect differ...cus bacteria, such as Escherichia Coli, Klebsiella...s, Streptococcus Agalactiae, and etc. With the pow...
...ect Cell Medium is optimized for serum-free growth... protein-free medium, Sf9 cultures routinely reach...ilities above 95%. This medium is also recommended...ng of pBACgus recombinants develops faster than ot...
GIBCO Grace's Insect Medium Supplemented (1X) liquid from Invitrogen
Virology LabFax from Promega
Biology Products: